Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K
Department of Biochemistry, National Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Nature. 1999 Dec 9;402(6762):656-60. doi: 10.1038/45230.
Small synthetic molecules called growth-hormone secretagogues (GHSs) stimulate the release of growth hormone (GH) from the pituitary. They act through GHS-R, a G-protein-coupled receptor for which the ligand is unknown. Recent cloning of GHS-R strongly suggests that an endogenous ligand for the receptor does exist and that there is a mechanism for regulating GH release that is distinct from its regulation by hypothalamic growth-hormone-releasing hormone (GHRH). We now report the purification and identification in rat stomach of an endogenous ligand specific for GHS-R. The purified ligand is a peptide of 28 amino acids, in which the serine 3 residue is n-octanoylated. The acylated peptide specifically releases GH both in vivo and in vitro, and O-n-octanoylation at serine 3 is essential for the activity. We designate the GH-releasing peptide 'ghrelin' (ghre is the Proto-Indo-European root of the word 'grow'). Human ghrelin is homologous to rat ghrelin apart from two amino acids. The occurrence of ghrelin in both rat and human indicates that GH release from the pituitary may be regulated not only by hypothalamic GHRH, but also by ghrelin.
一种名为生长激素促分泌素(GHSs)的小分子合成物质可刺激垂体释放生长激素(GH)。它们通过GHS-R发挥作用,GHS-R是一种G蛋白偶联受体,其配体尚不清楚。最近对GHS-R的克隆强烈表明,该受体确实存在内源性配体,并且存在一种调节GH释放的机制,该机制不同于下丘脑生长激素释放激素(GHRH)对其的调节。我们现在报告在大鼠胃中纯化并鉴定出一种对GHS-R具有特异性的内源性配体。纯化后的配体是一种由28个氨基酸组成的肽,其中第3位丝氨酸被正辛酰化。这种酰化肽在体内和体外均可特异性释放GH,并且第3位丝氨酸的O-正辛酰化对于其活性至关重要。我们将这种生长激素释放肽命名为“ghrelin”(ghre是印欧语系中“grow”一词的词根)。除了两个氨基酸外,人ghrelin与大鼠ghrelin同源。大鼠和人类体内均存在ghrelin,这表明垂体释放GH可能不仅受下丘脑GHRH的调节,还受ghrelin的调节。
Nature. 1999-12-9
Physiol Rev. 2005-4
Methods Enzymol. 2012
Curr Drug Targets Immune Endocr Metabol Disord. 2002-4
Minerva Endocrinol. 2002-12
Am J Physiol Endocrinol Metab. 2007-3
Best Pract Res Clin Endocrinol Metab. 2004-12
J Pediatr Endocrinol Metab. 2001
Front Med (Lausanne). 2025-7-28
Curr Obes Rep. 2025-7-28
Neurosci Appl. 2024-2-27